Abstract
Resection is the only chance for cure for patients with pancreatic, cancer. The extent of pancreatic, gastroduodenal, and lymph node, resection, however, remains a matter of debate. As the morbidity,and mortality rates of pancreatoduodenectomy have decreased, more extensive resections, such as regional pancreatectomy, have,become more feasible options. Nevertheless, tumor biology and,adjuvant therapy are the most important determinants of ultimate,outcome. Therefore, less extensive procedures (such as the pylorus-preserving pancreatoduodenectomy), which are associated with shorter operative time, reduced blood loss, and equally long but better quality of survival, are believed by many surgeons to be the optimal type of resection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
